is tirzepatide a glp-1 receptor agonist Tirzepatide, dual GIP/GLP-1 co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction TIRZEPATIDE VS. SEMAGLUTIDE — WHAT'S

Its truly a lifestyle change. In addition, weight losseven as little as 5 percentin overweight or obese individuals can help lower cardiovascular risk factors, including heart attacks and stroke

Each code corresponds to a specific drug, dosage, and administration route

Large scale clinical trials such as the LEADER trial, SUSTAIN-6 trial, Harmony Outcomes, PIONEER trial, REWIND trials have demonstrated the cardiovascular benefits of GLP-1RAs 5,6,7,8,9

It has since supported more than 100,000 members taking GLP-1s

Emerging Research Directions Researchers are still looking into what tirzepatide can do for people with non-alcoholic steatohepatitis (NASH), a disease that causes the liver to become very inflamed